EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Autologous bone marrow transplantation in non-Hodgkin lymphoma patients following different conditioning regimens: an 11-year single-center quasi-experimental study

Sahar Tavakoli Shiraji, Mohammad Biglari, Soroush Rad, Maryam Barkhordar, Hossein Kamranzadeh Foumani, Ghasem Janbabaei, Seied Asadollah Mousavi, Mohammad Vaezi, Kamran Mohammadi, Ardeshir Ghavamzadeh

Blood Research · 2026-12 · 61 (1)

DOI: 10.1007/s44313-026-00131-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Research, online erschienen am 09.04.2026. Verfasst von Sahar Tavakoli Shiraji und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Non-Hodgkin lymphoma (NHL) constitutes 90% of all lymphomas and accounts for 2.8% of new cancer cases and 2.6% of cancer-related deaths in 2020. Hematopoietic stem cell transplantation remains the standard treatment for refractory or relapsed NHL. Due to the shortage of carmustine, this study aimed to compare the outcomes of patients undergoing autologous stem cell transplantation (ASCT) with conditioning regimens that either include or exclude this drug over an 11-year period.

Methods

This retrospective study included a cohort of 240 patients with NHL who underwent ASCT with an EAM conditioning regimen, both with and without carboplatin. Following informed consent, clinical data from patients who underwent transplantation between March 2006 and May 2017 were collected. Patients were followed to assess overall survival (OS) and disease-free survival (DFS) as primary endpoints.

Results

No significant differences were observed between the survival outcomes of the two groups with differing conditioning regimens ( P = 0.27 for OS; P = 0.49 for DFS). The 3-year and 5-year OS rates were 81% and 74.8%, respectively, with a median follow-up of 74 months. The 3-year and 5-year DFS rates were 66.6% and 62.1%, respectively. OS and DFS were significantly higher in patients with B-cell lymphomas compared to those with T-cell lymphoma ( P < 0.01).

Conclusion

Our real-world data indicate that the addition of carboplatin to the EAM conditioning regimen does not significantly affect survival outcomes for patients with NHL undergoing ASCT.

Schlagwörter

Stichwörter der Autor:innen

Autologous stem cell transplantationCarboplatinConditioningNon-Hodgkin lymphomaSurvival

Autor:innen und Institutionen

  • Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Hematologic Malignancies Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran. Mohammad.biglari@lhsc.on.ca.
  • Verspeeten Family Cancer Center, London Health Sciences Research Institute, University of Western Ontario, London, ON, Canada. Mohammad.biglari@lhsc.on.ca.
  • Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Zitieren

APA

Tavakoli Shiraji, S., Biglari, M., Rad, S., Barkhordar, M., Foumani, H. K., Janbabaei, G., Mousavi, S. A., Vaezi, M., Mohammadi, K., & Ghavamzadeh, A. (2026). Autologous bone marrow transplantation in non-Hodgkin lymphoma patients following different conditioning regimens: an 11-year single-center quasi-experimental study. Blood Research, 61(1). https://doi.org/10.1007/s44313-026-00131-8

Vancouver

Tavakoli Shiraji S, Biglari M, Rad S, Barkhordar M, Foumani HK, Janbabaei G, et al. Autologous bone marrow transplantation in non-Hodgkin lymphoma patients following different conditioning regimens: an 11-year single-center quasi-experimental study. Blood Research. 2026;61(1). doi:10.1007/s44313-026-00131-8

BibTeX
@article{TavakoliShiraji2026,
  author = {Tavakoli Shiraji, Sahar and Biglari, Mohammad and Rad, Soroush and Barkhordar, Maryam and Foumani, Hossein Kamranzadeh and Janbabaei, Ghasem and Mousavi, Seied Asadollah and Vaezi, Mohammad and Mohammadi, Kamran and Ghavamzadeh, Ardeshir},
  title = {Autologous bone marrow transplantation in non-Hodgkin lymphoma patients following different conditioning regimens: an 11-year single-center quasi-experimental study},
  journal = {Blood Research},
  year = {2026},
  volume = {61},
  number = {1},
  doi = {10.1007/s44313-026-00131-8}
}
Kostenlos starten →